BIOCONPharmaceuticals

Biocon LtdFinancial Ratios & Key Metrics

360.90
-2.52%
P/E Ratio111.20xIndustry: 31.77x
ROE4.76%Return on equity
ROCE6.25%Return on capital
Debt/Equity0.62Low debt
💎

Valuation & Profitability

P/E Ratio
111.20x
Industry Average P/E
31.77x
Dividend Yield
0.13%
Market Cap
₹52.76K (Cr)
Sales Growth 5Y
19.11%
Profit Growth 5Y
7.16%
EPS Growth 5Y
7.15%
OPM 5Y Avg
21.68%
📉

Price Returns

1 Month
+6.02%
3 Months
+10.78%
6 Months
+17.27%
1 Year
+8.04%
52W Low
299
Current
361
52W High
425
49% of 52-week range — Mid range
🔬

Technical Indicators

39RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
378
▼ Price below SMA 50 — Bearish
SMA 200
374
▼ Long-term downtrend
Volume Signal
118% of avg
Average volume

Technical indicators are for educational purposes only. Not investment advice.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.